FIRM ANALYSIS NON-IP LITIGATION AND ENFORCEMENT
Firm Briefings
PRACTICE BREAKDOWN PER INDUSTRY SECTOR
We asked litigators (non-IP) to breakdown their practice by industry. The following represents a percentage of all respondents’ answers.
Agri-tech Medical Devices Pharmaceutical (Generic) Pharmaceutical (Branded) Biotechnology 0 10 20 30 40 50 60
work with that it would be impossible not to use them for a future matter,” one client enthuses. Hogan Lovells The government investigation practice at Hogan Lovells is viewed by competitors as “a top-notch group that is continuously active.” The firm does a lot of work defending clients on off-label marketing and clinical trial fraud issues, as well as counseling in AntiKickback act and FCA matters. “Their experience with global anti-corruption cases has positioned them well in the states in dealing with such matters,” adds another practitioner. Co-leader of the Investigations, White Collar, and Fraud practice area is Peter Spivack, who works on the full spectrum of matters in the market. “Few attorneys are able to counsel clients on as many issues as he can,” notes one colleague. He was lead counsel for one of the world’s largest orthopedic device manufacturers in a FDA-related, criminal investigation based on allegations of offlabel marketing. Strengthening Hogan’s practice is partner Stephen Immelt. “A leading authority in healthcare litigation, ” believes one rival attorney. Immelt has been working in the healthcare sector for over 20 years and has argued in over 20 federal districts on behalf of clients. “A strong team of lawyers who have helped a lot of clients get out of trouble,” says one competitor about Hogan’s product liability practice. With over 20 years of trying complex commercial litigations, partner Barry Thompson has earned the respect of his life sciences rivals. “Very good at constructing an argument and to top that off, one of the best guys I know in the industry,” praises one partner. Thompson has been counsel in the high-profile “PhenFen” and Vioxx cases.
Irwin Fritchie Urquhart & Moore Litigation boutique Irwin Fritchie Uqruhart & Moore has been a staple in life sciences product liability litigation for over 30 years. “We have worked with the firm in a lot of key matters for the industry and they are easy to collaborate with on behalf of clients,” believes one attorney. The firm continues to do product liability work focused on pharmaceutical and medical device companies. Both founding partners James Irwin and Quentin Urquhart have over 25 years of first-chair litigation experience. “Those attorneys have seen almost every trick in the book and are ready to handle anything that may come up over the course of litigation,” explains a competitor. Irwin and Urquhart are well-known for their litigation success in Louisiana. Kaye Scholer A deep bench of well-regarded litigators has rivals praising the work that Kaye Scholer is doing in both product liability and antirust. Both groups at the firm have done an immense amount of work for major players in the industry like Pfizer, Novartis, and Sandoz and continue to represent them in high profile litigious matters. A competing attorney believes that Kaye Scholer is, “Staffed with some of the most talented trial lawyers in the country.” Co-head of the firm’s life sciences group William Hoffman is doing extensive work in the product liability space. He is currently national counsel for Pfizer, defending the company’s heartburn medication Reglan. “One of the better product liability litigators who also has a fantastic appellate practice,” comments one practitioner. Partner Arthur Brown, who one peer refers to as “a pres-
LMG LIFE SCIENCES 2013
107